PlainRecalls
FDA Devices Moderate Class II Ongoing

COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.

Reported: November 25, 2020 Initiated: September 30, 2020 #Z-0401-2021

Product Description

COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.

Reason for Recall

The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.

Details

Recalling Firm
Merz North America, Inc.
Units Affected
2051 units
Distribution
US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV
Location
Franksville, WI

Frequently Asked Questions

What product was recalled?
COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.. Recalled by Merz North America, Inc.. Units affected: 2051 units.
Why was this product recalled?
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 25, 2020. Severity: Moderate. Recall number: Z-0401-2021.